How API regulatory geography is changing pharmaceutical procurement in 2026: FDA, EMA, GMP risks, new control areas and impact on TCO. Continue reading
Return to previous page
Page 2
As of early 2026, the concept of “procurement as a service” is finally a thing of the past. Our institute records a fundamental shift: procurement... Continue reading
CBAM as a tool of investment blackmail by the EU The Carbon Border Adjustment Mechanism (CBAM) is increasingly evidently going beyond climate policy. In 2026,... Continue reading
The focus of research in recent years has been on technologies for binding nutrients into stable matrices and forming controlled forms of fertilizers. Continue reading
Showing 11–14 of 14 posts
